G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse ...

A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has ...

PROTACs have helped redefine what may be possible in drug discovery. By harnessing the ubiquitin-proteasome system to ...

In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year. Grünenthal announced today that the company ...

SandboxAQ today announced a new virtual screening solution that helps drug developers identify promising candidates faster and at lower cost for G protein-coupled receptors (GPCRs), one of the most ...

Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...

Uterine fibroids and endometriosis are two of the most common gynecologic diseases, affecting 15% to 80% of women of ...

Nanotechnology has been applied extensively in drug delivery to improve the therapeutic outcomes of various diseases. Tremendous efforts have been focused on the development of novel nanoparticles and ...

Ligand-gated ion channels are ion channels that are opened or closed (gated) by ligands, generally small molecules such as the second messenger cAMP and neurotransmitters. Ligand-gated ion channels ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Daily science news on research developments and the latest scientific innovations Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech ...